The investment includes a commitment to provide services and sponsorship rights connected to the platform. The move formalizes a deeper business partnership between the company and the athlete, who has served as Herbalife’s global nutrition partner for over a decade.
From endorsement to ownership
Ronaldo’s relationship with Herbalife has historically focused on brand partnership, including collaboration on Herbalife24 CR7 Drive electrolyte drinks. His new position shift into an ownership role is tied to the company’s ongoing investment in digital strategy.
“Cristiano has been a valued partner for more than a decade, and his decision to take an ownership stake in Pro2col marks an important milestone in our relationship,” said Stephan Gratziani, chief executive officer of Herbalife, in a press release.
Gratziani added that Ronaldo’s investment “reflects a shared belief in the power of nutrition, data, AI and personalized insights to drive better health outcomes and reinforces his confidence in the future impact of Pro2col.”
Ronaldo expressed this confidence in a similar statement, saying that since 2013, when he began his partnership with Herbalife, the relationship has been nurtured by shared trust and mutual ambition. As such the investment in Pro2col “felt like a natural evolution—in addition to representing Herbalife, this is about helping shape and grow a platform that can truly change how people engage with their health and wellness,” he said.
“I’ve seen firsthand how Herbalife brings together science, innovation and personal support to make health and wellness more accessible, [and] working together with Herbalife to create something with lasting impact is what motivates me at this stage of my career,” he added.
Personalized platform strategy
Herbalife describes Pro2col as a digital operating system designed to support individualized wellness plans. The platform harnesses user data to build structured daily programs, track habits and monitor progress through Pro2Score, a proprietary scoring framework focused on key wellness indicators.
According to Herbalife, the technology is intended to support measurable outcomes while providing its distributor network with tools to enhance customer engagement.
A phased beta rollout is underway in the United States, Canada and Puerto Rico. Herbalife said the current stage is focused on gathering in-market feedback before broader commercialization, with expansion into select EMEA markets expected to begin later this year.
For industry stakeholders, Herbalife’s “long-term strategy to become a more connected, data-driven health and wellness platform” underscores continued investment in digital infrastructure and personalization tools that sit alongside finished products. The expansion follows similar brand investments announced in recent months, including Nutrafol’s myHutrafol app in December 2025.
The momentum driving expansion into digital health platforms is also spreading internationally, with Amway Korea launching its myWellness Lab personalized nutrition platform in South Korea last month.
